These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2021-002864-36 A prospective randomized, double-blind, placebo-controlled, multi-center phase III study to evaluate the efficacy and safety of mocravimod as an adjunctive and maintenance treatment in adult in acute ... not-yet-due
Exempt 2022-003618-35 A Phase 1b/2a dose escalation study to determine the recommended dose, efficacy, and tolerability of mocravimod in patients with large B cell lymphoma treated with a CD19 CAR T therapy not-yet-due